These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Athletes with systemic hypertension. Fagard RH Cardiol Clin; 2007 Aug; 25(3):441-8, vii. PubMed ID: 17961798 [TBL] [Abstract][Full Text] [Related]
3. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
4. Effects of high-intensity aerobic interval training vs. moderate exercise on hemodynamic, metabolic and neuro-humoral abnormalities of young normotensive women at high familial risk for hypertension. Ciolac EG; Bocchi EA; Bortolotto LA; Carvalho VO; Greve JM; Guimarães GV Hypertens Res; 2010 Aug; 33(8):836-43. PubMed ID: 20448634 [TBL] [Abstract][Full Text] [Related]
5. Hypertension in the elderly. Acelajado MC; Oparil S Clin Geriatr Med; 2009 Aug; 25(3):391-412. PubMed ID: 19765488 [TBL] [Abstract][Full Text] [Related]
6. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
8. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R; Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277 [TBL] [Abstract][Full Text] [Related]
9. Should sports activity be encouraged or contraindicated in hypertensive subjects? Penco M; Petroni R; Pastori F; Fratini S; Romano S J Cardiovasc Med (Hagerstown); 2006 Apr; 7(4):288-95. PubMed ID: 16645404 [TBL] [Abstract][Full Text] [Related]
10. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial. Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K; Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia. Abougalambou SS; Abougalambou AS; Sulaiman SA; Hassali MA Diabetes Metab Syndr; 2011; 5(3):115-9. PubMed ID: 22813562 [TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular characteristics of hypertension. Familial aspects. Neutel JM; Smith DH Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of exercise in young hypertensives. Palatini P Int J Sports Med; 2012 Sep; 33(9):683-90. PubMed ID: 22562742 [TBL] [Abstract][Full Text] [Related]
14. [A survey of factors influencing prognosis and control rate for patients with hypertension in mainland China]. Qi WH; Pan CY; Lin SY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):457-60. PubMed ID: 17711690 [TBL] [Abstract][Full Text] [Related]
15. Lack of control of high blood pressure and treatment recommendations in Canada. Khan N; Chockalingam A; Campbell NR Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423 [TBL] [Abstract][Full Text] [Related]
16. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD; Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449 [TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome in hypertension: European society of hypertension position statement. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G; J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611 [TBL] [Abstract][Full Text] [Related]
19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
20. Effects of continuous vs. interval exercise training on blood pressure and arterial stiffness in treated hypertension. Guimarães GV; Ciolac EG; Carvalho VO; D'Avila VM; Bortolotto LA; Bocchi EA Hypertens Res; 2010 Jun; 33(6):627-32. PubMed ID: 20379194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]